| Clinical Trial Scheme of Tanreqing Capsules in the Treatment of COVID-19 (NCT05305456) | Jiangsu Famous Medical Technology Co., Ltd. | 2022-03-28 |
| ACid Tranexamic or Terlipressin for Initial Emergency Treatment of Mild to seVere hEmoptysis: a Randomized Trial. (NCT04961528) | Assistance Publique - Hôpitaux de Paris | 2022-03-27 |
| Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant (NCT05317416) | Pfizer | 2022-03-25 |
| Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC) (NCT05348577) | AstraZeneca | 2022-03-25 |
| MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients (NCT04769895) | MaaT Pharma | 2022-03-25 |
| A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (NCT04928846) | AbbVie | 2022-03-25 |
| Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata (NCT05255237) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2022-03-25 |
| Bioequivalence Study of Tiotropium Bromide Inhalation Powder (NCT05161156) | Phargentis SA | 2022-03-24 |
| Study of Pembrolizumab/Vibostolimab Coformulation (MK-7684A) in Combination With Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (MK-7684A-007/KEYVIBE-007) (NCT05226598) | Merck Sharp & Dohme LLC | 2022-03-24 |
| A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors (NCT05135559) | Novo Nordisk A/S | 2022-03-24 |
| Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant (NCT05305040) | AlloVir | 2022-03-24 |
| Meningococcal Serogroup ACYWX Conjugate Vaccine in Comparison With MenACWY-TT Conjugate Vaccine (NCT05093829) | Emory University | 2022-03-24 |
| Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy (NCT05477576) | RayzeBio, Inc. | 2022-03-24 |
| Safety Study of Tivanisiran to Treat Dry Eye (NCT05310422) | Sylentis, S.A. | 2022-03-24 |
| Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008) (NCT05224141) | Merck Sharp & Dohme LLC | 2022-03-24 |
| A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood (NCT05147662) | Bayer | 2022-03-23 |
| A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction (NCT05316324) | Memorial Sloan Kettering Cancer Center | 2022-03-23 |
| A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China (NCT05662020) | Beijing Health Guard Biotechnology, Inc | 2022-03-23 |
| Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia (NCT05213104) | Assistance Publique - Hôpitaux de Paris | 2022-03-23 |
| An Extension Clinical Study of the Efficacy and Safety of BCD-132 in Patients With Multiple Sclerosis Who Previously Received Therapy in Clinical Studies of JSC BIOCAD (NCT06987851) | Biocad | 2022-03-22 |
| GA + ESP vs. SA + ESP in Lumbar Decompression Surgeries (NCT05444751) | Hospital for Special Surgery, New York | 2022-03-22 |
| Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine (NCT05216263) | AbbVie | 2022-03-22 |
| A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE） (NCT05295173) | Angde Biotech Pharmaceutical Co., Ltd. | 2022-03-21 |
| A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study (NCT05211947) | Boehringer Ingelheim | 2022-03-21 |
| Perioperative FLOT vs Adjuvant XELOX for CA Stomach (NCT05264896) | Chinese University of Hong Kong | 2022-03-21 |
| Efficacy, Safety, pharmacokinetiсs, Immunogenicity of GNR-067 and Lucentis® (NCT04667039) | AO GENERIUM | 2022-03-20 |
| Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys (NCT05430620) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2022-03-20 |
| Effectiveness of Glycyrrhizin as Intracanal Medication in Root Canal Disinfection and Inflammatory Cytokines (NCT06453304) | Mansoura University | 2022-03-20 |
| Treatment of Acute Ischemic STroke With Edaravone Dexborneol II (TASTE-2) (NCT05249920) | Beijing Tiantan Hospital | 2022-03-18 |
| TQB3616 Capsules Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer in Clinical Trail (NCT05375461) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-03-18 |
| Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13) (NCT04811092) | Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 2022-03-18 |
| Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine (NCT05249816) | Cogna Technology Solutions LLC | 2022-03-18 |
| Efficacy and Safety of Plecanatide Comparing With Placebo in the Treatment of Functional Constipation (NCT05151328) | Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. | 2022-03-18 |
| To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus (NCT05075408) | Galderma R&D | 2022-03-18 |
| Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis (NCT04804553) | Amgen | 2022-03-17 |
| Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA) (NCT04966702) | Barcelona Institute for Global Health | 2022-03-17 |
| A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression). (NCT05227209) | Sumitomo Pharma America, Inc. | 2022-03-17 |
| A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis. (NCT05338086) | mAbxience Research S.L. | 2022-03-16 |
| Enhanced CBTi for Older Adult Sleep and Cognition (NCT05015803) | Penn State University | 2022-03-16 |
| A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid Malignancies (NCT05301517) | Kyntra Bio | 2022-03-16 |
| A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines (NCT05248867) | AbbVie | 2022-03-16 |
| Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine (NCT05293665) | Vaxxinity, Inc. | 2022-03-16 |
| Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis (NCT04173169) | Yale University | 2022-03-15 |
| Pharmacokinetic (PK) Evaluation of Bemotrizinol (6%) in a Sunscreen Maximum Usage Trial (NCT05277376) | dsm-firmenich Switzerland AG | 2022-03-15 |
| Evaluation of Effect of Intravenous Morphine vs Intravenous Ibuprofen and Acetaminophen vs Intravenous Ibuprofen (NCT05630222) | Isfahan University of Medical Sciences | 2022-03-15 |
| Sulfur vs. Different Regimes of Permethrin for Scabies (NCT06396507) | Damascus University | 2022-03-15 |
| Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN) (NCT05248646) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2022-03-15 |
| CANPAIN Feasibility Study Pragmatic Real World Trial Investigating CBMP in Chronic Pain Patients (NCT05288010) | Harley Street (CPC) Limited | 2022-03-15 |
| Comparative Study Between Topical 5-fluorouracil and Latanoprost in Vitiligo. (NCT05513924) | South Valley University | 2022-03-15 |
| A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022) (NCT05239728) | Merck Sharp & Dohme LLC | 2022-03-15 |
| Dexmedetomine as Adjuvant for Spinal Anesthesia in Elective Cesarian Sections : a Pilot Study (NCT05099055) | St. Justine's Hospital | 2022-03-15 |
| Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients (NCT05277688) | Ruijin Hospital | 2022-03-15 |
| The Antibacterial Effect of Nanosilver Fluoride on Primary Teeth (NCT05221749) | Nour Ammar, BDS | 2022-03-15 |
| A Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops (NCT06209320) | Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | 2022-03-15 |
| The NIPA Study Naloxegol Administration to Prevent Opioids Induced Gastrointestinal Motility Disturbance in Brain Injured PAtients (NCT05008926) | University Hospital, Brest | 2022-03-15 |
| Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children (NCT06361992) | Catalysis SL | 2022-03-15 |
| Pain Control Without Opioids (NCT04813991) | Hackensack Meridian Health | 2022-03-15 |
| Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic Anemia (NCT05073458) | Incyte Corporation | 2022-03-15 |
| An Expanded Access Program in China to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options (NCT05239039) | Boehringer Ingelheim | 2022-03-15 |
| Empagliflozin and Dapagliflozin in Patients Hospitalized for Acute Decompensated Heart Failure (NCT05776043) | Medical University of Warsaw | 2022-03-15 |
| Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) (NCT05096663) | SWOG Cancer Research Network | 2022-03-15 |
| Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia (NCT05135286) | Visus Therapeutics | 2022-03-15 |
| Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy (NCT05586724) | Angelica Lindén Hirschberg | 2022-03-15 |
| A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia (FOVOCIP) (NCT07616635) | Fundación para la Investigación Biosanitaria del Principado de Asturias | 2022-03-14 |
| Using Dexmedetomidine Prior to Intubation in Neonates (NCT05304598) | Maimonides Medical Center | 2022-03-14 |
| Inhalational (Sevoflurane) Versus Intravenous (Propofol) Sedation in Adults With a Moderate Form of ARDS (NCT05259631) | Negovsky Reanimatology Research Institute | 2022-03-14 |
| Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers (NCT05255107) | Peschke GmbH | 2022-03-14 |
| Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. (NCT05111626) | Amgen | 2022-03-14 |
| Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers (NCT05255016) | Peschke GmbH | 2022-03-14 |
| SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes (NCT04889183) | University Medical Center Groningen | 2022-03-14 |
| A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies. (NCT05027802) | Ipsen | 2022-03-14 |
| Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma (NCT05317819) | Polaris Group | 2022-03-14 |
| Efficacy and Safety of JT001 (VV116) Compared With Favipiravir (NCT05279235) | Shanghai Vinnerna Biosciences Co., Ltd. | 2022-03-14 |
| A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea. (NCT05296629) | Journey Medical Corporation | 2022-03-14 |
| A Pragmatic Trial to Determine the Benefit of Behaviorally Enhanced Exercise Incentives and Corticosteroid Injections in Osteoarthritis of the Knee Marching On for Veterans With Osteoarthritis of the Knee (NCT05035810) | VA Office of Research and Development | 2022-03-14 |
| Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patients: A Randomized Phase III Trial (NCT05367206) | Sun Yat-sen University | 2022-03-14 |
| A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia (NCT05311254) | Fundación para la Investigación Biosanitaria del Principado de Asturias | 2022-03-14 |
| A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer (NCT05257395) | Xuanzhu Biopharmaceutical Co., Ltd. | 2022-03-14 |
| Evaluation of Glucocorticoids Plus Rituximab in Patients With Newly-Diagnosed or Relapsing IgA Vasculitis (NCT05329090) | Hopital Foch | 2022-03-11 |
| A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease (NCT05206773) | Sanofi | 2022-03-11 |
| Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Prefilled Syringe (NCT05161806) | Sandoz | 2022-03-11 |
| Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer (NCT05169567) | Eli Lilly and Company | 2022-03-11 |
| A Study of Safety, Reactogenicity and Immune Response of the Repeat Vaccination Against RSV When Given to Female Participants of 18-49 Years of Age During Their Subsequent Uncomplicated Pregnancy (NCT05229068) | GlaxoSmithKline | 2022-03-11 |
| Empagliflozin for the Treatment of Postprandial Hypoglycemia (NCT05036317) | University Hospital, Basel, Switzerland | 2022-03-11 |
| Evaluation of Emerging New Treatments for Infection Prevention in Total Joint Replacement (NCT05084378) | Hamilton Health Sciences Corporation | 2022-03-11 |
| A Study of Parsaclisib, a PI3Kδ Inhibitor, in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma (NCT04849715) | Incyte Corporation | 2022-03-11 |
| A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma (NCT05100862) | BeOne Medicines | 2022-03-10 |
| Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy (NCT04904536) | The George Institute | 2022-03-10 |
| Low Dose Dexamethasone for Distal Radius Fractures (NCT05274113) | Rothman Institute Orthopaedics | 2022-03-10 |
| Efficiency of Tadalafil for Management of Female Sexual Dysfunction (NCT05266651) | Kasr El Aini Hospital | 2022-03-10 |
| COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases (NCT05236491) | Paul R Fortin | 2022-03-09 |
| Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern (NCT05251402) | University of Illinois at Chicago | 2022-03-09 |
| BEMPEG With Pembrolizumab vs Pembrolizumab Alone in Patients With Metastatic or Recurrent HNSCC (PROPEL-36) (NCT04969861) | Nektar Therapeutics | 2022-03-09 |
| Intranasal Dexmedetomidine Versus Oral Midazolam as Premedication for Propofol Sedation in Pediatric Patients Undergoing Magnetic Resonance Imaging (NCT05192629) | Brugmann University Hospital | 2022-03-09 |
| Remimazolam vs Midazolam Cognitive and Motor Recovery After Intravenous Conscious Sedation for Dental Extractions. (NCT05220462) | Guy's and St Thomas' NHS Foundation Trust | 2022-03-09 |
| TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer (NCT05188313) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2022-03-09 |
| Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity (NCT04966741) | Rhythm Pharmaceuticals, Inc. | 2022-03-08 |
| Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO (NCT05078047) | UNICANCER | 2022-03-08 |
| A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naïve Adult Participants With Glabellar Lines (NCT05248880) | AbbVie | 2022-03-08 |
| A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder. (NCT05064878) | Zogenix, Inc. | 2022-03-08 |